Dong-A ST is a South Korea-based pharmaceutical company and corporate strategic investor backing companies aligned with pharmaceutical R&D, life sciences and biotechnology. Based in Seoul, it is relevant for early-stage healthcare and genetic-medicines companies seeking strategic corporate capital, with investment activity spanning South Korea and the United States.